Bacterial control through dispersion of bacteriophage powders

Inventors

Tawil, Nancy

Assignees

Precisiobiotix Technologies Inc • Precisio Biotix Therapeutics Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12396460-B2

Patent

Publication Date

2025-08-26

Expiration Date


Abstract

A method of eliminating, reducing or preventing bacterial contamination of a surface, the method comprising dispersing a bacteriophage containing composition in air in proximity to the surface. In some embodiments, the bacteriophage containing composition is a powder dispersed by pressurizing a load chamber containing the powder so that the powder is expelled through an outlet. Also, devices for performing the method and a powder used in the method.

Core Innovation

The invention concerns using bacteriophage-containing powder to at least partially disinfect a surface exposed to air. The powder is dispersed nonpyrogenically by a dry dispersion mechanism near the surface, so that some powder reaches it. The provided content also describes lyophilized bacteriophage particles and optional auxiliary particles as components of the powder.

The provided content contrasts this approach with fogging, reporting dispersal without phage-toxic gases or stringent temperature and humidity control. It describes the intended outcome as bacterial lysis on the surface by the bacteriophages. The background section itself is not included in the supplied material, so no further problem statement can be identified.

Claims Coverage

One independent claim is provided, covering one inventive feature directed to nonpyrogenic dry dispersion of bacteriophage powder.

Nonpyrogenic dry dispersion of bacteriophage-containing powder

The independent claim recites providing a powder that includes bacteriophages and dispersing it in the air near an air-exposed surface so that at least part of the powder is applied to the surface. The powder is dispersed nonpyrogenically using a dry dispersion mechanism.

The independent claim centers on applying bacteriophage-containing powder to an air-exposed surface through nonpyrogenic dry dispersion for partial disinfection.

Stated Advantages

The powder is reported to disperse near-instantaneously compared with fogging.

The described approach avoids phage-toxic gases and stringent temperature and humidity control.

In some embodiments, the powder is reported to retain room-temperature stability for over 600 days.

Documented Applications

Partial disinfection of surfaces in rooms, vehicles, and conduits.

Disinfection of wounds and outdoor surfaces.

Pulmonary delivery.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.